A new study published in the journal of Arthritis Care & Research showed that in individuals with gout, usage of Febuxostat ...

MANCHESTER, England — Febuxostat (Uloric) did not appear to increase the risk for major adverse cardiovascular (CV) events (MACEs) when compared with no urate-lowering therapy (ULT) in people ...

Learn everything you need to know about Febuxostat-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, precautions ...

Review the side-effects of Febuxostat as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of ...

For one, a product called dotinurad already approved in Japan, a pivotal study conducted in China indicated that the agent was more effective than febuxostat (Uloric). Meanwhile, findings from a 6 ...

The U.S. branch of India’s Sun Pharma issued a voluntary recall of more than 55,000 bottles of febuxostat tablets used to treat gout after a report of microbial contamination in the company's ...

Credit: sumroeng chinnapan / Shutterstock.com. Sun Pharmaceutical Industries has announced a recall of 55,000 bottles of Febuxostat, a medication used to treat gout, from the US market, PTI has ...

Drug major Sun Pharma is recalling around 55,000 bottles of a generic medication to treat gout from the American market due to manufacturing practices norms deviations, according to the US health ...

The product will be manufactured at Lupin’s Pithampur facility in India. Febuxostat Tablets, 40 mg and 80 mg, are indicated for the chronic management of hyperuricemia in adult patients with ...

Credit: Getty Images. Major effects of febuxostat on renal outcome might be uric acid dependent, according to investigators. Beside reducing serum uric acid in patients with chronic kidney disease ...

Hyperuricemia is frequently observed among patient with chronic kidney disease. Febuxostat may offer superior renal-protective effects compared with allopurinol in patients with stage 3 chronic ...